Skip to main content
. Author manuscript; available in PMC: 2009 Dec 9.
Published in final edited form as: Vaccine. 2008 Oct 16;26(52):6874–6882. doi: 10.1016/j.vaccine.2008.09.077

Figure 1. Levofloxacin treatment rescues mice from intranasal SCHU S4 infection.

Figure 1

Balb/c mice were given 3 LD50 doses (103 CFU) of SCHU S4 via intra-nasal challenge, and then 24 hours later given 6.25 mg/kg body weight of levofloxacin via intra-peritoneal injections. As a control, mice were injected with PBS. Mice (10 mice per group) were given levofloxacin or PBS daily for thirteen days. Mice were monitored twice daily for up to two months.